-
iNtRON Biotechnology, Inc. attended the 38th Annual J.P. Morgan Health..
21 January,2020 -
Challenges faced in the CRO industry as drug development advances to t..
20 January,2020 -
The Head of Lifetech Research Center, Dr. Kang(CFO), Won a President C..
02 January,2020 -
Roivant Sciences and iNtRON Bio Sign Licensing Deal for Novel Anti-Sup..
20 November,2018 -
First Endolysin-based Orphan Drug Designated by US FDA
29 June,2018 -
Nightmare bacteria’ are trying to spread in the U.S.
10 April,2018 -
Management of multi-drug resistant organisms in healthcare settings
26 March,2018 -
AMR Industry Alliance Progress Report Published – SAL200 as “Notable T..
18 January,2018 -
N-Rephasin® SAL200 Phase 1b Multiple Ascending Dose (MAD) Study Initia..
18 January,2018 -
Endolysin Based Treatment for Anthrax in Nature-Scientific Reports
17 January,2018
